Who has invested in IASO Biotherapeutics?

CDH Baifu, CCB International, Everbright Limited, Co-Stone Capital, CNCB Capital, Plaisance Capital are named among the investors backing IASO Biotherapeutics.

IASO Biotherapeutics Funding: $178M Raised, Series C (2021)

IASO Biotherapeutics funding overview

IASO Biotherapeutics is based in Pleasanton, California. IASO Biotherapeutics has raised $178M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series C announced in September 2021. The round record for IASO Biotherapeutics runs through 2021; nothing later has been disclosed. Investors on record include CDH Baifu, CCB International, Everbright Limited, Co-Stone Capital, CNCB Capital, Plaisance Capital and 2 others. 8 distinct backers are named across the disclosed rounds.

IASO Biotherapeutics at a glance

Total raised: $178M
Latest round: Series C
Latest round date: September 2021
Headquarters: Pleasanton, California
Notable investors: CDH Baifu, CCB International, Everbright Limited, Co-Stone Capital, CNCB Capital, Plaisance Capital, GL Ventures, Hillhouse Capital

Frequently asked about IASO Biotherapeutics funding

How much has IASO Biotherapeutics raised?: IASO Biotherapeutics has raised $178M in total disclosed funding across the rounds on record.
Who has invested in IASO Biotherapeutics?: CDH Baifu, CCB International, Everbright Limited, Co-Stone Capital, CNCB Capital, Plaisance Capital are named among the investors backing IASO Biotherapeutics.
What was the latest IASO Biotherapeutics funding round?: The most recent disclosed round is a Series C, announced in September 2021.
Where is IASO Biotherapeutics based?: IASO Biotherapeutics is based in Pleasanton, California.
When did IASO Biotherapeutics last raise?: The last disclosed IASO Biotherapeutics round closed in September 2021 at Series C.

IASO Biotherapeutics totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Pleasanton below to benchmark round size and investor mix.

IASO Biotherapeutics Funding: $178M Raised, Series C (2021)

IASO Biotherapeutics funding overview

IASO Biotherapeutics at a glance

Frequently asked about IASO Biotherapeutics funding

Companies related to IASO Biotherapeutics (20)

Browse related funding lists (4)